Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer

✍ Scribed by M. Albertsson; B. Johansson; S. Friesland; L. Kadar; H. Letocha; G. Frykholm; G. Wagenius

• Book ID: 107576606
• Publisher: Springer US
• Year: 2007
• Tongue: English
• Weight: 133 KB
• Volume: 24
• Category: Article
• ISSN: 1357-0560
• DOI: 10.1007/s12032-007-0028-6